 SAN DIEGO, CA ACCESSWIRE March 24, 2022 Ensysce Biosciences, Inc. Ensysce or the Company NASDAQ:ENSCOTC PINK:ENSCW, a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety and performance with a focus on reducing abuse and overdose while providing relief for those with severe pain, today announced plans to release fourth quarter and full year 2021 financial results after close of market on Thursday, March 31, 2022. Corporate Update Conference Call Management will host a corporate update conference call on Wednesday, April 6, 2022, at 11:00 a.m. 